- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Gastric Motility Disorder Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Theravance, Inc
Targacept, Inc
ChironWells GmbH
Concert Pharmaceuticals, Inc
By Type:
Others
TD-8954
Velusetrag
Ipamorelin
By Application:
Home Use
Clinic
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Gastric Motility Disorder Drug Market Overview 2018-2029
-
1.1 China Gastric Motility Disorder Drug Industry Development Overview
-
1.2 China Gastric Motility Disorder Drug Industry Development History
-
1.3 China Gastric Motility Disorder Drug Industry Market Size (2018-2029)
-
1.4 China Gastric Motility Disorder Drug Market Analysis by Type from Production Side
-
1.4.1 China Gastric Motility Disorder Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.2 China Gastric Motility Disorder Drug Production Volume, Production Value and Growth Rate of TD-8954 (2018-2029)
-
1.4.3 China Gastric Motility Disorder Drug Production Volume, Production Value and Growth Rate of Velusetrag (2018-2029)
-
1.4.4 China Gastric Motility Disorder Drug Production Volume, Production Value and Growth Rate of Ipamorelin (2018-2029)
-
1.5 China Gastric Motility Disorder Drug Market Analysis by Application from Consumption End
-
1.5.1 China Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate of Home Use (2018-2029)
-
1.5.2 China Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.3 China Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China Gastric Motility Disorder Drug Market Analysis by Region
-
1.6.1 North China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Gastric Motility Disorder Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Gastric Motility Disorder Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Gastric Motility Disorder Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Gastric Motility Disorder Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Gastric Motility Disorder Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Gastric Motility Disorder Drug Industry Development
Chapter 3 Gastric Motility Disorder DrugIndustry Chain Analysis
-
3.1 Gastric Motility Disorder Drug Industry Chain
-
3.2 Gastric Motility Disorder Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Gastric Motility Disorder Drug Market
-
3.3 Gastric Motility Disorder Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Gastric Motility Disorder Drug Market
Chapter 4 China Gastric Motility Disorder Drug Market, by Type
-
4.1 China Gastric Motility Disorder Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Gastric Motility Disorder Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Gastric Motility Disorder Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Gastric Motility Disorder Drug Production Volume and Growth Rate of Others
-
4.5.2 China Gastric Motility Disorder Drug Production Volume and Growth Rate of TD-8954
-
4.5.3 China Gastric Motility Disorder Drug Production Volume and Growth Rate of Velusetrag
-
4.5.4 China Gastric Motility Disorder Drug Production Volume and Growth Rate of Ipamorelin
Chapter 5 China Gastric Motility Disorder Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Gastric Motility Disorder Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Gastric Motility Disorder Drug Market Size and Growth Rate, by Application
-
5.5.1 China Gastric Motility Disorder Drug Market Size and Growth Rate of Home Use
-
5.5.2 China Gastric Motility Disorder Drug Market Size and Growth Rate of Clinic
-
5.5.3 China Gastric Motility Disorder Drug Market Size and Growth Rate of Hospital
Chapter 6 China Gastric Motility Disorder Drug Market, by Region
-
6.1 China Gastric Motility Disorder Drug Production Volume and Production Value, by Region
-
6.2 China Gastric Motility Disorder Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Gastric Motility Disorder Drug Market Analysis
-
7.1 North China Gastric Motility Disorder Drug Market, by Type
-
7.2 North China Gastric Motility Disorder Drug Market, by Application
Chapter 8 Central China Gastric Motility Disorder Drug Market Analysis
-
8.1 Central China Gastric Motility Disorder Drug Market, by Type
-
8.2 Central China Gastric Motility Disorder Drug Market, by Application
Chapter 9 South China Gastric Motility Disorder Drug Market Analysis
-
9.1 South China Gastric Motility Disorder Drug Market, by Type
-
9.2 South China Gastric Motility Disorder Drug Market, by Application
Chapter 10 East China Gastric Motility Disorder Drug Market Analysis
-
10.1 East China Gastric Motility Disorder Drug Market, by Type
-
10.2 East China Gastric Motility Disorder Drug Market, by Application
Chapter 11 Northeast China Gastric Motility Disorder Drug Market Analysis
-
11.1 Northeast China Gastric Motility Disorder Drug Market, by Type
-
11.2 Northeast China Gastric Motility Disorder Drug Market, by Application
Chapter 12 Southwest China Gastric Motility Disorder Drug Market Analysis
-
12.1 Southwest China Gastric Motility Disorder Drug Market, by Type
-
12.2 Southwest China Gastric Motility Disorder Drug Market, by Application
Chapter 13 Northwest China Gastric Motility Disorder Drug Market Analysis
-
13.1 Northwest China Gastric Motility Disorder Drug Market, by Type
-
13.2 Northwest China Gastric Motility Disorder Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Theravance, Inc
-
14.1.1 Theravance, Inc Company Profile
-
14.1.2 Theravance, Inc Gastric Motility Disorder Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Targacept, Inc
-
14.2.1 Targacept, Inc Company Profile
-
14.2.2 Targacept, Inc Gastric Motility Disorder Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 ChironWells GmbH
-
14.3.1 ChironWells GmbH Company Profile
-
14.3.2 ChironWells GmbH Gastric Motility Disorder Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Concert Pharmaceuticals, Inc
-
14.4.1 Concert Pharmaceuticals, Inc Company Profile
-
14.4.2 Concert Pharmaceuticals, Inc Gastric Motility Disorder Drug Market Performance
-
14.4.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Gastric Motility Disorder Drug Industry Research Conclusions
-
15.2 Gastric Motility Disorder Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Gastric Motility Disorder Drug Industry Market Size (2018-2029)
-
Figure China Gastric Motility Disorder Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Gastric Motility Disorder Drug Production Volume, Production Value and Growth Rate of TD-8954 (2018-2029)
-
Figure China Gastric Motility Disorder Drug Production Volume, Production Value and Growth Rate of Velusetrag (2018-2029)
-
Figure China Gastric Motility Disorder Drug Production Volume, Production Value and Growth Rate of Ipamorelin (2018-2029)
-
Figure China Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate of Home Use (2018-2029)
-
Figure China Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Gastric Motility Disorder Drug Market Size and Growth Rate from 2018-2029
-
Figure Gastric Motility Disorder Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Gastric Motility Disorder Drug Market Share by Type in 2018
-
Figure China Gastric Motility Disorder Drug Market Share by Type in 2023
-
Figure China Gastric Motility Disorder Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Gastric Motility Disorder Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Gastric Motility Disorder Drug Production Volume and Growth Rate of TD-8954 (2018-2023)
-
Figure China Gastric Motility Disorder Drug Production Volume and Growth Rate of Velusetrag (2018-2023)
-
Figure China Gastric Motility Disorder Drug Production Volume and Growth Rate of Ipamorelin (2018-2023)
-
Figure China Gastric Motility Disorder Drug Market Share by Application in 2018
-
Figure China Gastric Motility Disorder Drug Market Share by Application in 2023
-
Figure China Gastric Motility Disorder Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Gastric Motility Disorder Drug Market Size and Growth Rate of Home Use (2018-2023)
-
Figure China Gastric Motility Disorder Drug Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Gastric Motility Disorder Drug Market Size and Growth Rate of Hospital (2018-2023)
-
Table China Gastric Motility Disorder Drug Production Volume by Region (2018-2023)
-
Table China Gastric Motility Disorder Drug Production Volume Share by Region (2018-2023)
-
Figure China Gastric Motility Disorder Drug Production Volume Share by Region (2018-2023)
-
Table China Gastric Motility Disorder Drug Production Value by Region (2018-2023)
-
Table China Gastric Motility Disorder Drug Production Value Share by Region (2018-2023)
-
Figure China Gastric Motility Disorder Drug Production Value Share by Region (2018-2023)
-
Table China Gastric Motility Disorder Drug Sales Volume by Region (2018-2023)
-
Table China Gastric Motility Disorder Drug Sales Volume Share by Region (2018-2023)
-
Figure China Gastric Motility Disorder Drug Sales Volume Share by Region (2018-2023)
-
Table China Gastric Motility Disorder Drug Sales Value by Region (2018-2023)
-
Table China Gastric Motility Disorder Drug Sales Value Share by Region (2018-2023)
-
Figure China Gastric Motility Disorder Drug Sales Value Share by Region (2018-2023)
-
Table North China Gastric Motility Disorder Drug Production Volume by Type (2018-2023)
-
Table North China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Figure North China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Table North China Gastric Motility Disorder Drug Sales Volume by Application (2018-2023)
-
Table North China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Gastric Motility Disorder Drug Production Volume by Type (2018-2023)
-
Table Central China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Table Central China Gastric Motility Disorder Drug Sales Volume by Application (2018-2023)
-
Table Central China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Table South China Gastric Motility Disorder Drug Production Volume by Type (2018-2023)
-
Table South China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Figure South China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Table South China Gastric Motility Disorder Drug Sales Volume by Application (2018-2023)
-
Table South China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Table East China Gastric Motility Disorder Drug Production Volume by Type (2018-2023)
-
Table East China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Figure East China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Table East China Gastric Motility Disorder Drug Sales Volume by Application (2018-2023)
-
Table East China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Gastric Motility Disorder Drug Production Volume by Type (2018-2023)
-
Table Northeast China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Gastric Motility Disorder Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Gastric Motility Disorder Drug Production Volume by Type (2018-2023)
-
Table Southwest China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Gastric Motility Disorder Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Gastric Motility Disorder Drug Production Volume by Type (2018-2023)
-
Table Northwest China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Gastric Motility Disorder Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Gastric Motility Disorder Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Gastric Motility Disorder Drug Sales Volume Share by Application (2018-2023)
-
Table Theravance, Inc Company Profile
-
Table Theravance, Inc Gastric Motility Disorder Drug Revenue, Price and Gross (2018-2023)
-
Table Targacept, Inc Company Profile
-
Table Targacept, Inc Gastric Motility Disorder Drug Revenue, Price and Gross (2018-2023)
-
Table ChironWells GmbH Company Profile
-
Table ChironWells GmbH Gastric Motility Disorder Drug Revenue, Price and Gross (2018-2023)
-
Table Concert Pharmaceuticals, Inc Company Profile
-
Table Concert Pharmaceuticals, Inc Gastric Motility Disorder Drug Revenue, Price and Gross (2018-2023)
-